These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2706431)

  • 1. Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease activity and duration.
    Black CM; McWhirter A; Harrison NK; Kirk JM; Laurent GJ
    Br J Rheumatol; 1989 Apr; 28(2):98-103. PubMed ID: 2706431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis.
    Guseva NG; Anikina NV; Myllylä R; Risteli L; Risteli J; Chochlova JV; Kivirikko KI; Nassonova VA
    Ann Rheum Dis; 1991 Jul; 50(7):481-6. PubMed ID: 1831604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous neutrophil activation in patients with primary Raynaud's phenomenon and systemic sclerosis.
    Stevens TR; Hall ND; McHugh NJ; Maddison PJ
    Br J Rheumatol; 1992 Dec; 31(12):856. PubMed ID: 1458295
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma TGF beta in systemic sclerosis: a cross-sectional study.
    Snowden N; Coupes B; Herrick A; Illingworth K; Jayson MI; Brenchley PE
    Ann Rheum Dis; 1994 Nov; 53(11):763-7. PubMed ID: 7826139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxyterminal type I procollagen peptide concentrations in systemic sclerosis: higher levels in early diffuse disease.
    Scheja A; Hellmer G; Wollheim FA; Akesson A
    Br J Rheumatol; 1993 Jan; 32(1):59-62. PubMed ID: 8422562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
    Scheja A; Akesson A; Hørslev-Petersen K
    Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma urotensin II levels in primary Raynaud's phenomenon and systemic sclerosis.
    Gözel N; Karataş A; Yardım M; Kınacı MS; Ulu R; Demircan F; Kılınç F; Öz B; Dönder E; Aydın S; Koca SS
    Turk J Med Sci; 2017 Dec; 47(6):1687-1692. PubMed ID: 29306224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
    Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of serum III procollagen for diagnosis of pulmonary involvement in patients with scleroderma.
    Diot E; Diot P; Valat C; Boissinot E; Asquier E; Lemarie E; Guilmot JL
    Eur Respir J; 1995 Sep; 8(9):1559-65. PubMed ID: 8575585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon.
    Biondi ML; Marasini B; Bianchi E; Agostoni A
    Int J Cardiol; 1988 Jun; 19(3):335-9. PubMed ID: 3397197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.
    Kahaleh MB; Osborn I; LeRoy EC
    Ann Intern Med; 1981 Apr; 94(4 pt 1):482-4. PubMed ID: 6782927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hand warming as a treatment for Raynaud's phenomenon in systemic sclerosis.
    Goodfield MJ; Rowell NR
    Br J Dermatol; 1988 Nov; 119(5):643-6. PubMed ID: 3207617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma.
    Krieg T; Langer I; Gerstmeier H; Keller J; Mensing H; Goerz G; Timpl R
    J Invest Dermatol; 1986 Dec; 87(6):788-91. PubMed ID: 3782862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.